Science ❯ Biotechnology

Vaccine Technology

mRNA Technology mRNA Vaccines Infectious Diseases Manufacturing Processes Microparticles mRNA Applications Immunology Research Facilities saRNA Technology Thermal Stability Vaccine Design Recombinant Vaccines Viral Vaccines Virus-Like Particles

UVA Team Tests DNA-Programmed Bacterial Vaccine Platform Aimed at Weeks-Long Development

The UVA platform remains in preclinical testing with patent applications filed by the university.

CEPI Puts Up to $54.3 Million Behind Moderna’s H5 mRNA Bird Flu Vaccine for Phase 3

Thermostable, Single-Injection Rabies Vaccine From CU Boulder Reports Strong Mouse Data

US Cuts $500 Million in mRNA Vaccine Research Funding

HHS Withdraws $766 Million for Moderna’s Bird Flu mRNA Vaccine

Trans-amplifying mRNA vaccine delivers broad SARS-CoV-2 variant protection with 40-fold lower dosage

HHS Withdraws $766 Million From Moderna’s Bird Flu Vaccine Program